Objective To evaluate the level of ribosomal RNA (rRNA) in cumulus cells (CCs) from women with polycystic ovary syndrome (PCOS) undergoing ICSI. Materials and methods The study population included three healthy oocyte donors (control) and three patients with PCOS. RNA expression in CCs was assessed using quantitative realtime PCR assay to measure the pre-rRNA transcripts (5′ETS region), 18 S, 5.8 S and 28 S rRNA. Results The level of 18 S rRNA is 3.9 times higher (p0 0.036) and the level of 5.8 S rRNA is 2.9 times higher (p0 0.049) in CCs of PCOS patients than in CCs of healthy women. The fold change in expression of 28 S rRNA in CCs of PCOS patients also exceeds that in the control group, but did not reach a statistical significance (p00.342). Conclusion Our observations support the idea that CCs of PCOS patients contain comparatively more ribosomes that CCs of healthy oocyte donors that may indicate a higher proliferation rate or up-regulated translation of protein factors in ССs of PCOS patients.
Introduction
It is well known that protein synthesis directly correlates with the synthesis and amount of ribosomes present in a cell [1, 2] . For example, cells capable of proliferation or excreting proteins are more enriched in ribosomes than non-proliferating cells or cells that do not produce proteins for export. A large amount of ribosomes and ribosomal RNA (rRNA) is also accumulated in oocytes during their maturation [3] . The major role in ribosome synthesis is played by the nucleolus, where the three major classes of rRNA, namely 18 S rRNA, 5.8 S rRNA, and 28 S rRNA, are transcribed as a single 47 S prerRNA precursor and processed to produce mature cytoplasmic rRNAs [4] (Fig. 1a) . In somatic cells, certain amounts of 18 S, 5.8 S, and 28 S rRNA are present in transcriptionally active nucleoli, but the vast majority of mature rRNAs are docked by cytoplasmic ribosomes.
Cumulus cells (CCs) are specialized somatic cells that surround and nourish oocytes by providing a number of specific proteins and enzymes such as GREMI, BDNF, PGKI, CDC42, STAR, and CYP19AI, which are required for oocyte development and fertilization [5] . One could expect, therefore, that disturbances in protein synthesis in cumulus cells may have negative effects on the oocyte quality. However, to the best of our knowledge, ribosome biogenesis has not been studied in CCs of either healthy women or patients with fertility dysfunction. To shed light on this question, we examined the amount of pre-rRNA transcript, 18 S, 5.8 S and 28 S rRNA in the CCs of patients with polycystic ovary syndrome (PCOS), which is a frequent woman infertility disorder that increases the risk for ovarian hyperstimulation syndrome, using quantitative reverse transcription real-time PCR (qRT-PCR).
Materials and methods

Study population
The study population included oocytes of three women with PCOS and of three healthy oocyte donors (the control group). The patients were diagnosed with PCOS on the basis of the ESHRE/ASRM Rotterdam Consensus Meeting criteria (2003) and underwent IVF/ICSI in the "AltraVita" IVF clinic (Moscow, Russia). In the same clinic the healthy donors underwent ovarian stimulation. The women with PCOS had oligomenorrhea or amenorrhea, clinical or biochemical evidence of hyperandrogenism and polycystic ovaries on ultrasound scan with no hyperprolactinemia, thyroid hormone disorders or congenital adrenal hyperplasia. Their clinical, endocrine and ultrasound parameters versus healthy oocyte donors are summarized in Table 1 . The controlled ovarian stimulation was performed using a recombinant FSH (average total dose of 1480 IU for the patients and 2270 IU for the donors) and GnRH antagonist. The retrieval of oocytes was n-the number of women in each group, in parentheses the ranges of parameters are indicated performed after 36 h of hCG administration under ultrasound guidance; the average number of oocytes collected was 27 for the patients and 23 for the donors which were underwent IVF/ ICSI procedure. 18 oocytes (MII stage) from one healthy oocyte donor were vitrified. The patients, donors, their oocytes and embryos were not subjected to any procedures which did not satisfy the clinically approved protocols and rules of the Russian Ministry of Health for assisted reproductive technologies (№ 67 by 26/02/2003). The study was approved by the local ethics committee of "AltraVita" IVF clinic. All of the patients signed an official informed consent for participation in the experiment
Cumulus cells collection and total RNA isolation After collection of the ova, the oocyte-cumulus complexes were immediately separated from the follicular fluid and washed in HTF flushing medium (CooperSurgical, Trumbull, USA). Approximately 5×10 2 CCs were detached from an oocyte with a sharp needle under a dissecting microscope Stemi 2000-C (Carl Zeiss AG, Berlin, Germany) and used for total RNA extraction with a ChargeSwitch RNA Kit (Invitrogen, Paisley, UK). Other CCs were removed by denuding of oocytes in Quinn's Advantage® Medium with HEPES (CooperSurgical) in presence of 15 IU/ml hyaluronidase (CooperSurgical). The reverse transcription reactions were performed immediately after RNA isolation using AMVreverse transcriptase, random primers and dNTPs (Fermentas, Chembridge, UK) following the manufacturer's instructions.
Quantitative reverse transcription real-time PCR (qRT-PCR)
RNA expression was assessed using qRT-PCR assay to assess the amounts of pre-rRNA transcripts (5′ETS region), 18 S, 5.8 S and 28 S rRNA (Fig. 1a) . The primers and FAMconjugated probes for human rRNA (GenBank ID: U13369.1) were designed using AlleleID 7.7 software (PREMIER Biosoft, Palo Alto, USA) and synthesized by "DNA-Synthesis" (Moscow, Russia). The primer and probe sequences are indicated in Table 2 . The positions of the amplicons are shown in Fig. 1a . Human beta-actin mRNA (GenBank ID: NM_001101.3) was used to normalize the amount of isolated RNA in each sample. The master mix, qPCRmix-HS (Evrogen, Moscow, Russia), and 2 μl of cDNA were used in a PCR reaction. qRT-PCR was performed three times for each amplicon (i.e., 5′ETS, 18 S, 5.8 S, and 28 S rRNA and beta-actin mRNA) using a MiniOpticon RT-PCR system (BioRad, Hercules, USA) with the following parameters: 5 min denaturation at 95 C and 40 PCR cycles for 15 s at 95 C, 20 s at 55 C and 20 s at 72 C. Melting curve analysis and gel electrophoresis were used to control the specificity and quality of PCR. The data were analyzed using Bio-Rad CFX software (BioRad). Fold-induction values (n) were calculated using the following formula n02 -ΔΔCt , where Ct represents the mean threshold cycle of all replicate analyses of a given amplicon and ΔCt represents the difference between the Ct values of the target amplicon and the Ct value of the reference gene (beta-actin) [6] . The statistical analysis was performed using Kruskal-Wallis ANOVA on rank using Origin 5.0 software (OriginLab, Northampton, USA), p<0.05 was considered statistically significant.
Results
The major clinical, endocrine and ultrasound parameters of PCOS patients and healthy oocyte donors are summarized in Table 1 . One can see that almost all parameters for the both groups are compatible with exception of the levels of LH and testosterone and of the number of ultrasound follicles, which were higher in PCOS patients than in the control group. These observations are in accordance with the ESHRE/ASRM Rotterdam Consensus Meeting criteria for PCOS disorder symptoms [7] . The major nuclear parameters of oocytes after denuding CCs such as the number of mature and immature oocytes, fertilization and blastocyst rates in the both groups of women are summarized in Table 3 . They demonstrate that slightly more GV oocytes, but less MI and MII oocytes were obtained from PCOS patients than from healthy oocyte donors, but in the both groups of women oocytes at the MII stage was the dominating type amongst all isolated oocytes. The cytoplasmic maturation stage of MII oocytes before ICSI was similar in the both groups. Under a light microscope (Leica DMI4000, Leica Microsystems GmbH, Berlin, Germany) with a lens×20/NA 0.4 Ph2 the cytoplasm of oocytes was rather homogenous and devoted of granular aggregates or vacuole clustering. The oocyte fertilization rate was lower in PCOS patients (79 %) than in healthy donors (93 %) ( Table 3 ). The blastocyst rate at the days 5th and 6th after ICSI, which assessed only blastocysts of the excellent and good quality, was also lower in PCOS patients (42 %) than in healthy donors (69 %) ( Table 3 ).
The total amount of 5′ETS, 18 S, 5.8 S, and 28 S rRNA and beta-actin mRNA was analyzed in CCs detached from 102 oocytes underwent ICSI, including 45 oocytes obtained from three PCOS patients and 57 oocytes obtained from three healthy oocyte donors. The levels of pre-rRNA (5′ ETS) and 18 S, 5.8 S and 28 S rRNA in CCs of healthy donors was normalized to the level of beta-actin mRNA and revealed equal amounts. As shown in Fig. 1b , the relative content of two classes of rRNAs-18 S and 5.8 S rRNA -is statistically augmented in CCs of PCOS patients in comparison with that in CCs of healthy donors. Namely, the level of 18 S rRNA is 3.9 times higher (p00.036) and the level of 5.8 S rRNA is 2.9 times higher (p00.049). The fold change in the level of 28 S rRNA was also increased in CCs of PCOS patients, but the difference did not reach a statistically significant value (p 00.342). Similar results were also obtained for the 5′ETS region of pre-rRNA (p0 0.648), which amount is a measure of rDNA transcription rate in nucleoli.
Discussion
PCOS is the most common female endocrinopathy, affecting 5-10 % of women of reproductive age, and it is associated with 75 % of anovulatory infertility disorders [8] . The impediment of ovarian function in PCOS patients can affect both the quality of CCs and oocytes. In this study, we showed that CCs of PCOS patients contain higher amounts of 18 S and 5.8 S rRNA which are synthesized in nucleoli to comprise cytoplasmic ribosomes. This finding argues in favor of a higher content of ribosomes and, apparently, of an up-regulated level of total protein synthesis in CCs of women with PCOS.
Ribosome biogenesis is an evolutionarily conserved process. In eukaryotes, it starts in the nucleolus with transcription of the common pre-rRNA precursor for 18 S, 5.8 S, and 28 S rRNAs (Fig. 1a) and ends in the cytoplasm with the formation of mature ribosomes. In the nucleolus, pre-rRNA forms stable links with proteins of cytoplasmic ribosomes and transient links with proteins involved in rRNA maturation [4] . rRNA transcription and ribosome biogenesis are controlled by a number of cellular pathways such as the PI3 kinase/mTOR, MYC and RAS/ERK pathways, whereas augmented rRNA synthesis is necessarily for cell proliferation and growth [2, 9, 10] .
Therefore, it is tempting to speculate that higher amounts of rRNA present in CCs of PCOS patients are resulted from a higher proliferation rate of the cells. This assumption is in a good concordance with recent findings which demonstrate increased proliferation and decreased apoptotic rates in granulosa cells of PCOS patients [11] .
Alternatively, higher levels of 18 S and 5.8 S rRNA in CCs of PCOS patients may be associated with an elevated level of proteins or enzymatic factor in CCs. As far as the complex signaling between CCs and oocytes is bidirectional via the gap junctions formed by CCs and zona pellucida of oocytes [12] , one could suppose that activation of ribosomal gene expression in CCs of woman with PCOS may lead to disturbances in oocyte-cumulus communications and development of embryos after ICSI. In a line with this assumption, we observed differences in the number of mature MII oocytes, fertilization and blastocyst rates between PCOS patients and healthy oocyte donors, which were lower in the patients (Table 3) . Thus, the level of rRNA in CCs of PCOS patients reversibly correlates with the outcome of mature oocytes and embryos. However, we can not completely exclude that the higher level of rRNA in CCs of PCOS patients may result from specific (i.e., different from the healthy oocyte donors) reaction of PCOS patients to ovarian stimulation. Nowadays, data on rRNA amount in CCs of patients with other reproductive disorders, which could contribute to discussion of this admission, are absent.
To shed more light on a link between a higher amount of rRNA in CCs and oocyte developmental capacities in PCOS patients, further studies should be undertaken.
